An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-0178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Trastuzumab Resistance: What Are We Offering to Breast Cancer Patients?

Journal of Clinical & Experimental Oncology
2017English

Gastric Cancer and Trastuzumab: First Biologic Therapy in Gastric Cancer

Therapeutic Advances in Medical Oncology
Oncology
2013English

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

Molecular Cell
Cell BiologyMolecular Biology
2012English

Acquired Resistance to Cancer Chemotherapy.

BMJ
1984English

Trastuzumab-Resistance and Breast Cancer

2011English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2014English

Monoclonal Antibodies Against Autocrine Motility Factor Suppress Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Evolution of Acquired Resistance to Anti-Cancer Therapy

Journal of Theoretical Biology
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology SimulationImmunologyBiological SciencesMedicineAgriculturalModeling
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy